InvestSMART

BTC Health Ltd (ASX:BTC)

ALERT: Price-sensitive ASX Announcement for BTC
Current share price for BTC : $0.060 0 (0%)+
Announcement
Release
20 Aug 2026 7:19PM
Price at Release
$0.060
Full Release
download
Summary
In the FY2026 Investor Presentation, BTC Health Ltd reported stable group revenue of $10.27 million, with a significant contribution from the Cardio segment, which grew by 31% and now represents 57% of group revenue. The company achieved a statutory profit after tax of $34,728, a noticeable decrease from FY25 due to the absence of a large fair value gain on investments. Operating costs were reduced by 2% to $4.23 million, and group cash increased by 61% to $2.08 million following a successful $1.96 million share placement. The company highlighted a strategic shift towards diversifying its product and customer base, with strong growth in cardiac products including Corcym heart valves and CPB cannulas. BTC Health aims to continue expanding its Cardio segment and converting infusion pump users to newer products like Elasto-Q and Micrel in the coming fiscal year.
Key Points
  • Group revenue steady at $10.27 million.
  • Cardio segment represents 57% of revenue with 31% growth.
  • Statutory profit after tax of $34,728.
  • Operating costs reduced by 2% to $4.23 million.
  • Group cash increased by 61% to $2.08 million.
  • $1.96 million share placement completed.
  • Emphasis on product and customer diversification.
  • Corcym heart valves and CPB cannulas showed strong growth.
  • Strategic focus on expanding Cardio segment and infusion pumps transition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.